HTTP 200 OK
Allow: GET
Content-Type: application/json
Vary: Accept
{
"url": "https://lda.senate.gov/api/v1/filings/c796ad03-7104-45b6-b022-9bd8507cd5ac/?format=api",
"filing_uuid": "c796ad03-7104-45b6-b022-9bd8507cd5ac",
"filing_type": "Q1",
"filing_type_display": "1st Quarter - Report",
"filing_year": 2021,
"filing_period": "first_quarter",
"filing_period_display": "1st Quarter (Jan 1 - Mar 31)",
"filing_document_url": "https://lda.senate.gov/filings/public/filing/c796ad03-7104-45b6-b022-9bd8507cd5ac/print/",
"filing_document_content_type": "text/html",
"income": null,
"expenses": "70000.00",
"expenses_method": "a",
"expenses_method_display": "Method A - Reporting amounts using LDA definitions only",
"posted_by_name": "Brian Connell",
"dt_posted": "2021-04-20T23:25:38.477000-04:00",
"termination_date": null,
"registrant_country": "United States of America",
"registrant_ppb_country": null,
"registrant_address_1": "10 G St NE",
"registrant_address_2": "Suite 400",
"registrant_different_address": true,
"registrant_city": "Washington",
"registrant_state": "DC",
"registrant_zip": "20002",
"registrant": {
"id": 60218,
"url": "https://lda.senate.gov/api/v1/registrants/60218/?format=api",
"house_registrant_id": 35351,
"name": "BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)",
"description": "Non-profit patient advocacy organization",
"address_1": "10 G St NE",
"address_2": "Suite 400",
"address_3": null,
"address_4": null,
"city": "Washington",
"state": "DC",
"state_display": "District of Columbia",
"zip": "20002",
"country": "US",
"country_display": "United States of America",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"contact_name": "BRIAN CONNELL",
"contact_telephone": "+1 202-969-1805",
"dt_updated": "2026-01-27T12:15:37.715696-05:00"
},
"client": {
"id": 160887,
"url": "https://lda.senate.gov/api/v1/clients/160887/?format=api",
"client_id": 12,
"name": "BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)",
"general_description": null,
"client_government_entity": false,
"client_self_select": true,
"state": "DC",
"state_display": "District of Columbia",
"country": "US",
"country_display": "United States of America",
"ppb_state": "DC",
"ppb_state_display": "District of Columbia",
"ppb_country": "US",
"ppb_country_display": "United States of America",
"effective_date": "2013-01-28"
},
"lobbying_activities": [
{
"general_issue_code": "HCR",
"general_issue_code_display": "Health Issues",
"description": "HR 1319, The American Rescue Plan Act, specifically provisions ; S 466, Protecting Americans with Pre-existing Conditions Act; S 1002, The Junk Plan Accountability and Disclosure (JPADA) Act; HR 1875, PHA Amendment Re: STLDI; HR 369, the Health Care Affordability Act; HR 892, Pre-Existing Conditions Protection Act of 2021; HR 1872, MORE Health Education Act; HR 1890, Network Adequacy Standards for QHPs; HR 1896, State Allowance for Variety of Exchanges Act; HR 1887, State Health Care Premium Reduction Act of 2021; HR 1790, Fair Indexing for Health Care Affordability; S 245, the States Achieve Medicaid Expansion Act (aka SAME Act); HR 1390, CHIPPER Act; HR 1791, CHIP Permanency Act; HR 1738, Stabilize Medicaid and CHIP Coverage Act (Dingell) Continuous Enrollment; HR 340, Incentivizing Medicaid Expansion Act; S. 464/H.R. 2163, the Safe Step Act; the promoting racial and socioeconomic diversity in clinical trials; FDA regulations regarding sites of delivery for clinical trial services; federal regulation of association health plans; federal regulation of employer-provided health benefit plans; implementation of the No Surprises Act (enacted in the 116th Congress); the Cancer Drug Parity Act (not yet introduced); the No Junk Plans Act (not yet introduced); federal regulation of junk insurance plans",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 61060,
"prefix": null,
"prefix_display": null,
"first_name": "BRIAN",
"nickname": null,
"middle_name": null,
"last_name": "CONNELL",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
},
{
"lobbyist": {
"id": 79139,
"prefix": null,
"prefix_display": null,
"first_name": "KATIE",
"nickname": null,
"middle_name": "ANN",
"last_name": "BERGE",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": true
},
{
"lobbyist": {
"id": 91915,
"prefix": null,
"prefix_display": null,
"first_name": "MATTHEW",
"nickname": null,
"middle_name": null,
"last_name": "MARKS",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": true
}
],
"government_entities": [
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 1,
"name": "SENATE"
}
]
},
{
"general_issue_code": "MMM",
"general_issue_code_display": "Medicare/Medicaid",
"description": "Medicare Part D benefit design reform, including out-of-pocket maximum with monthly smoothing; the CMMI Part D Payment Modernization Model Request for Applications, FY2022",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 61060,
"prefix": null,
"prefix_display": null,
"first_name": "BRIAN",
"nickname": null,
"middle_name": null,
"last_name": "CONNELL",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
},
{
"lobbyist": {
"id": 79139,
"prefix": null,
"prefix_display": null,
"first_name": "KATIE",
"nickname": null,
"middle_name": "ANN",
"last_name": "BERGE",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": true
},
{
"lobbyist": {
"id": 91915,
"prefix": null,
"prefix_display": null,
"first_name": "MATTHEW",
"nickname": null,
"middle_name": null,
"last_name": "MARKS",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": true
}
],
"government_entities": [
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 1,
"name": "SENATE"
}
]
},
{
"general_issue_code": "BUD",
"general_issue_code_display": "Budget/Appropriations",
"description": "HR 1319, The American Rescue Plan Act, specifically provisions appropriating funding for the Centers for Disease Control and other covid-19 control programs; FY22 appropriations for the Department of Health & Human Services, specifically funding for the National Institutes of Health and the Center for Medicare & Medicaid Services; FY22 appropriations for the Department of Defense, specifically the CDMRP Peer-Reviewed Cancer Research Program",
"foreign_entity_issues": "",
"lobbyists": [
{
"lobbyist": {
"id": 61060,
"prefix": null,
"prefix_display": null,
"first_name": "BRIAN",
"nickname": null,
"middle_name": null,
"last_name": "CONNELL",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
},
{
"lobbyist": {
"id": 79139,
"prefix": null,
"prefix_display": null,
"first_name": "KATIE",
"nickname": null,
"middle_name": "ANN",
"last_name": "BERGE",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": true
},
{
"lobbyist": {
"id": 91915,
"prefix": null,
"prefix_display": null,
"first_name": "MATTHEW",
"nickname": null,
"middle_name": null,
"last_name": "MARKS",
"suffix": null,
"suffix_display": null
},
"covered_position": null,
"new": false
}
],
"government_entities": [
{
"id": 2,
"name": "HOUSE OF REPRESENTATIVES"
},
{
"id": 1,
"name": "SENATE"
}
]
}
],
"conviction_disclosures": [],
"foreign_entities": [],
"affiliated_organizations": []
}